Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness of the Abatacept (Orencia®) IV and SC Patient Alert Cards in Patients With Rheumatoid Arthritis in European Economic Area Countries

NCT02632890 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT02632890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02632890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness of the Abatacept (Orencia®) IV and SC Patient Alert Cards in Patients With Rheumatoid Arthritis in European Economic Area Countries
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
November 29, 2016
Completion date
April 28, 2017
Enrollment
203 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis